Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +65.07%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +50.07%
#5 Velvet Velvet +44.04%
#6 Black Phoenix Black Phoenix +34.24%
#7 Cross Cross +27.93%
#8 Cap Cap +17.71%
#9 DoubleZero DoubleZero +14.64%
#10 Pieverse Pieverse +10.18%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Classifica tra le azioni #39175
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Prezzo delle azioni
$0.378
Ultima sincronizzazione: 2024-05-24
Capitalizzazione di mercato
$618.41K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia NeuBase Therapeutics, Inc. (NBSE)

Categoria

Healthcare
Il prezzo NBSE con la capitalizzazione del mercato della B
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
NBSE
$0.378
Capitalizzazione di mercato di NeuBase Therapeutics, Inc.(NBSE)
Capitalizzazione di mercato: $618.41K
A partire dal August 2026, NeuBase Therapeutics, Inc. ha una capitalizzazione di mercato pari a $618.41K. Questo rende NeuBase Therapeutics, Inc. la 39175th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di NeuBase Therapeutics, Inc. dal 2004 al 2026
NBSE in paragone con la classifica dei più popolari stocks
Il prezzo per NBSE Attivo B Capitalizzazione del mercato a B Risultati
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$3,343,238 $618.41K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +884,454,463.65%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,730,484 $618.41K
Apple Inc. Apple Inc.
AAPL
$4.467T +722,350,064.17%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,551,581 $618.41K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +675,021,304.38%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,261,661 $618.41K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +598,322,901.89%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$1,744,708 $618.41K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +461,562,929.50%